Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects.

PubWeight™: 2.66‹?› | Rank: Top 1%

🔗 View Article (PMC 295829)

Published in J Clin Invest on May 01, 1995

Authors

L J Goodyear1, F Giorgino, L A Sherman, J Carey, R J Smith, G L Dohm

Author Affiliations

1: Research Division, Joslin Diabetes Center, Boston, MA 02215, USA.

Articles citing this

Obesity and insulin resistance. J Clin Invest (2000) 10.47

Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. J Clin Invest (1999) 6.73

Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling. Biochem J (1998) 3.94

Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle. J Clin Invest (2000) 3.79

Elevated stearoyl-CoA desaturase-1 expression in skeletal muscle contributes to abnormal fatty acid partitioning in obese humans. Cell Metab (2005) 3.47

Role of mitochondrial dysfunction in insulin resistance. Circ Res (2008) 3.45

Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance. J Clin Invest (1999) 3.36

Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats. J Clin Invest (1999) 3.18

Normal insulin-dependent activation of Akt/protein kinase B, with diminished activation of phosphoinositide 3-kinase, in muscle in type 2 diabetes. J Clin Invest (1999) 2.00

Evidence for defects in the trafficking and translocation of GLUT4 glucose transporters in skeletal muscle as a cause of human insulin resistance. J Clin Invest (1998) 1.82

Insulin receptor substrate (IRS) 1 is reduced and IRS-2 is the main docking protein for phosphatidylinositol 3-kinase in adipocytes from subjects with non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci U S A (1997) 1.73

Alterations in skeletal muscle protein-tyrosine phosphatase activity and expression in insulin-resistant human obesity and diabetes. J Clin Invest (1997) 1.58

TBC1D1 regulates insulin- and contraction-induced glucose transport in mouse skeletal muscle. Diabetes (2010) 1.55

The role of membrane glycoprotein plasma cell antigen 1/ectonucleotide pyrophosphatase phosphodiesterase 1 in the pathogenesis of insulin resistance and related abnormalities. Endocr Rev (2008) 1.52

A common amino acid polymorphism in insulin receptor substrate-1 causes impaired insulin signaling. Evidence from transfection studies. J Clin Invest (1996) 1.50

Attenuated mTOR signaling and enhanced autophagy in adipocytes from obese patients with type 2 diabetes. Mol Med (2010) 1.48

Insulin sensitivity and mitochondrial function are improved in children with burn injury during a randomized controlled trial of fenofibrate. Ann Surg (2007) 1.36

Central role of E3 ubiquitin ligase MG53 in insulin resistance and metabolic disorders. Nature (2013) 1.35

Human adenovirus type 36 enhances glucose uptake in diabetic and nondiabetic human skeletal muscle cells independent of insulin signaling. Diabetes (2008) 1.31

PTG gene deletion causes impaired glycogen synthesis and developmental insulin resistance. J Clin Invest (2003) 1.27

Bioactives of Artemisia dracunculus L enhance cellular insulin signaling in primary human skeletal muscle culture. Metabolism (2008) 1.27

Abnormal myocardial insulin signalling in type 2 diabetes and left-ventricular dysfunction. Eur Heart J (2009) 1.26

Template to improve glycemic control without reducing adiposity or dietary fat. Am J Physiol Endocrinol Metab (2011) 1.25

Gosha-jinki-gan (a Herbal Complex) Corrects Abnormal Insulin Signaling. Evid Based Complement Alternat Med (2004) 1.24

Deletion of SOCS7 leads to enhanced insulin action and enlarged islets of Langerhans. J Clin Invest (2005) 1.14

Characterization of the Met326Ile variant of phosphatidylinositol 3-kinase p85alpha. Proc Natl Acad Sci U S A (2002) 1.11

E4orf1: a novel ligand that improves glucose disposal in cell culture. PLoS One (2011) 1.11

The UPS in diabetes and obesity. BMC Biochem (2008) 1.08

Increased skeletal muscle tumor necrosis factor-alpha and impaired insulin signaling persist in obese women with gestational diabetes mellitus 1 year postpartum. Diabetes (2007) 1.07

Rapamycin does not improve insulin sensitivity despite elevated mammalian target of rapamycin complex 1 activity in muscles of ob/ob mice. Am J Physiol Regul Integr Comp Physiol (2008) 1.03

Modulation of skeletal muscle insulin signaling with chronic caloric restriction in cynomolgus monkeys. Diabetes (2009) 1.03

Lipid partitioning, incomplete fatty acid oxidation, and insulin signal transduction in primary human muscle cells: effects of severe obesity, fatty acid incubation, and fatty acid translocase/CD36 overexpression. J Clin Endocrinol Metab (2010) 1.03

Short-term overeating induces insulin resistance in fat cells in lean human subjects. Mol Med (2009) 1.00

Insulin resistance of glucose uptake in skeletal muscle cannot be ameliorated by enhancing endothelium-dependent blood flow in obesity. J Clin Invest (1998) 1.00

Severe obesity: evidence for a deranged metabolic program in skeletal muscle? Exerc Sport Sci Rev (2012) 0.99

Insulin resistance in striated muscle-specific integrin receptor beta1-deficient mice. J Biol Chem (2008) 0.97

Failure of dietary quercetin to alter the temporal progression of insulin resistance among tissues of C57BL/6J mice during the development of diet-induced obesity. Diabetologia (2009) 0.97

Skeletal muscle insulin resistance: the interplay of local lipid excess and mitochondrial dysfunction. Metabolism (2009) 0.95

Phosphorylation of the insulin receptor by AMP-activated protein kinase (AMPK) promotes ligand-independent activation of the insulin signalling pathway in rodent muscle. Diabetologia (2011) 0.93

Insulin-mimetic and insulin-sensitizing activities of a pentacyclic triterpenoid insulin receptor activator. Biochem J (2007) 0.92

Chronic insulin effects on insulin signalling and GLUT4 endocytosis are reversed by metformin. Biochem J (2000) 0.92

Methionine sulfoxide reductase A affects insulin resistance by protecting insulin receptor function. Free Radic Biol Med (2012) 0.91

Accelerated atherosclerosis in Apoe-/- mice heterozygous for the insulin receptor and the insulin receptor substrate-1. Arterioscler Thromb Vasc Biol (2011) 0.91

Insulin-like growth factor-I-stimulated insulin receptor substrate-1 negatively regulates Src homology 2 domain-containing protein-tyrosine phosphatase substrate-1 function in vascular smooth muscle cells. J Biol Chem (2010) 0.91

A steady state analysis indicates that negative feedback regulation of PTP1B by Akt elicits bistability in insulin-stimulated GLUT4 translocation. Theor Biol Med Model (2004) 0.90

Diabetes and the role of inositol-containing lipids in insulin signaling. Mol Med (1999) 0.87

Cellular location of insulin-triggered signals and implications for glucose uptake. Pflugers Arch (2005) 0.87

Is there a metabolic program in the skeletal muscle of obese individuals? J Obes (2011) 0.87

Insulin-like growth factor-I stimulates differentiation of ATII cells to ATI-like cells through activation of Wnt5a. Am J Physiol Lung Cell Mol Physiol (2013) 0.87

Insulin resistance, obesity, hypertension, and renal sodium transport. Int J Hypertens (2011) 0.87

Regulation of insulin signal transduction pathway by a small-molecule insulin receptor activator. Biochem J (2002) 0.86

Insulin receptor-independent upregulation of cellular glucose uptake. Int J Obes (Lond) (2012) 0.86

Insulin sensitivity is related to fat oxidation and protein kinase C activity in children with acute burn injury. J Burn Care Res (2008) 0.85

Combined thiazolidinedione-metformin treatment synergistically improves insulin signalling to insulin receptor substrate-1-dependent phosphatidylinositol 3-kinase, atypical protein kinase C and protein kinase B/Akt in human diabetic muscle. Diabetologia (2008) 0.83

Activation of G proteins by GIV-GEF is a pivot point for insulin resistance and sensitivity. Mol Biol Cell (2015) 0.83

C1-Ten is a protein tyrosine phosphatase of insulin receptor substrate 1 (IRS-1), regulating IRS-1 stability and muscle atrophy. Mol Cell Biol (2013) 0.83

Insulin signalling and resistance in patients with chronic heart failure. J Physiol (2003) 0.82

Plexin D1 determines body fat distribution by regulating the type V collagen microenvironment in visceral adipose tissue. Proc Natl Acad Sci U S A (2015) 0.82

Regulation of insulin receptor substrate-1 by mTORC2 (mammalian target of rapamycin complex 2). Biochem Soc Trans (2013) 0.81

Effect of insulin levels on the phosphorylation of specific amino acid residues in IRS-1: implications for burn-induced insulin resistance. Int J Mol Med (2009) 0.80

Impaired glucose tolerance in pediatric burn patients at discharge from the acute hospital stay. J Burn Care Res (2010) 0.80

Expression of the splice variants of the p85alpha regulatory subunit of phosphoinositide 3-kinase in muscle and adipose tissue of healthy subjects and type 2 diabetic patients. Biochem J (2001) 0.80

Obesity, insulin resistance, and skeletal muscle nitric oxide synthase. J Appl Physiol (1985) (2012) 0.79

Obesity-associated Gingival Vascular Inflammation and Insulin Resistance. J Dent Res (2014) 0.79

Six-minute walk test in non-insulin-dependent diabetes mellitus patients living in Northwest Africa. Diabetes Metab Syndr Obes (2012) 0.78

Obesity-induced insulin resistance in human skeletal muscle is characterised by defective activation of p42/p44 MAP kinase. PLoS One (2013) 0.78

Judicious Toggling of mTOR Activity to Combat Insulin Resistance and Cancer: Current Evidence and Perspectives. Front Pharmacol (2016) 0.77

Role of renal proximal tubule transport in thiazolidinedione-induced volume expansion. World J Nephrol (2012) 0.76

Hepatitis C virus NS5A promotes insulin resistance through IRS-1 serine phosphorylation and increased gluconeogenesis. World J Gastroenterol (2015) 0.76

Genetic Variation and Insulin Resistance in Middle-Aged Chinese Men. Ann Hum Genet (2015) 0.75

Differential Effects of Oral and Intravenous Lipid Administration on Key Molecules Related to Energy Homeostasis. J Clin Endocrinol Metab (2016) 0.75

Effect of Alkaloids from Nelumbinis Plumula against Insulin Resistance of High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease in Mice. J Diabetes Res (2016) 0.75

Selective Insulin Resistance in the Kidney. Biomed Res Int (2016) 0.75

E4orf1 Enhances Glucose Uptake Independent of Proximal Insulin Signaling. PLoS One (2016) 0.75

Evaluation of common variants in MG53 and the risk of type 2 diabetes and insulin resistance in Han Chinese. Springerplus (2016) 0.75

Ginsenoside Re rapidly reverses insulin resistance in muscles of high-fat diet fed rats. Metabolism (2012) 0.75

Articles cited by this

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem (1976) 903.81

Replacement of insulin receptor tyrosine residues 1162 and 1163 compromises insulin-stimulated kinase activity and uptake of 2-deoxyglucose. Cell (1986) 8.87

Phosphatidylinositol 3-kinase encoded by yeast VPS34 gene essential for protein sorting. Science (1993) 7.86

Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes (1988) 7.80

Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature (1994) 6.50

Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature (1991) 6.50

PDGF-dependent tyrosine phosphorylation stimulates production of novel polyphosphoinositides in intact cells. Cell (1989) 6.26

Type I phosphatidylinositol kinase makes a novel inositol phospholipid, phosphatidylinositol-3-phosphate. Nature (1988) 5.88

The insulin signaling system. J Biol Chem (1994) 5.25

Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation. Mol Cell Biol (1994) 5.13

Insulin stimulates the phosphorylation of the 95,000-dalton subunit of its own receptor. Science (1982) 5.01

Human insulin receptors mutated at the ATP-binding site lack protein tyrosine kinase activity and fail to mediate postreceptor effects of insulin. J Biol Chem (1987) 4.32

Activation of phosphatidylinositol 3-kinase by insulin. Proc Natl Acad Sci U S A (1990) 4.32

PI 3-kinase is a dual specificity enzyme: autoregulation by an intrinsic protein-serine kinase activity. EMBO J (1994) 3.39

Replacement of lysine residue 1030 in the putative ATP-binding region of the insulin receptor abolishes insulin- and antibody-stimulated glucose uptake and receptor kinase activity. Proc Natl Acad Sci U S A (1987) 2.99

An in vitro human muscle preparation suitable for metabolic studies. Decreased insulin stimulation of glucose transport in muscle from morbidly obese and diabetic subjects. J Clin Invest (1988) 2.86

Surgical treatment of obesity and its effect on diabetes: 10-y follow-up. Am J Clin Nutr (1992) 2.62

Insulin activates a tyrosine-specific protein kinase in extracts of 3T3-L1 adipocytes and human placenta. Proc Natl Acad Sci U S A (1982) 2.40

Insulin receptor kinase in human skeletal muscle from obese subjects with and without noninsulin dependent diabetes. J Clin Invest (1987) 2.36

Phosphatidylinositol kinase or an associated protein is a substrate for the insulin receptor tyrosine kinase. J Biol Chem (1990) 2.35

Regulation of insulin receptor substrate-1 in liver and muscle of animal models of insulin resistance. J Clin Invest (1992) 2.31

Inhibition of the translocation of GLUT1 and GLUT4 in 3T3-L1 cells by the phosphatidylinositol 3-kinase inhibitor, wortmannin. Biochem J (1994) 2.30

Tyrosine phosphorylation of the insulin receptor beta subunit activates the receptor-associated tyrosine kinase activity. J Biol Chem (1984) 2.21

Insulin stimulation of phosphatidylinositol 3-kinase activity and association with insulin receptor substrate 1 in liver and muscle of the intact rat. J Biol Chem (1992) 2.06

Insulin-stimulated GLUT4 translocation is relevant to the phosphorylation of IRS-1 and the activity of PI3-kinase. Biochem Biophys Res Commun (1993) 2.03

A tightly associated serine/threonine protein kinase regulates phosphoinositide 3-kinase activity. Mol Cell Biol (1993) 1.95

Evidence against altered expression of GLUT1 or GLUT4 in skeletal muscle of patients with obesity or NIDDM. Diabetes (1990) 1.93

The disposal of an oral glucose load in healthy subjects. A quantitative study. Diabetes (1985) 1.88

YMXM motifs of IRS-1 define substrate specificity of the insulin receptor kinase. Proc Natl Acad Sci U S A (1992) 1.79

Decreased kinase activity of insulin receptors from adipocytes of non-insulin-dependent diabetic subjects. J Clin Invest (1987) 1.76

Phorbol ester-induced serine phosphorylation of the insulin receptor decreases its tyrosine kinase activity. J Biol Chem (1988) 1.74

Studies on the mechanism of insulin resistance in the liver from humans with noninsulin-dependent diabetes. Insulin action and binding in isolated hepatocytes, insulin receptor structure, and kinase activity. J Clin Invest (1986) 1.67

Defect in skeletal muscle phosphatidylinositol-3-kinase in obese insulin-resistant mice. J Clin Invest (1993) 1.62

Insulin stimulation of phosphatidylinositol 3-kinase activity maps to insulin receptor regions required for endogenous substrate phosphorylation. J Biol Chem (1992) 1.50

The insulin and insulin-like growth factor-I receptor substrate IRS-1 associates with and activates phosphatidylinositol 3-kinase in vitro. J Biol Chem (1993) 1.48

Phosphatidylinositol-3-kinase in isolated rat adipocytes. Activation by insulin and subcellular distribution. J Biol Chem (1992) 1.43

Decreased expression of glucose transporter in muscle from insulin-resistant patients. Am J Physiol (1991) 1.36

Expression of insulin regulatable glucose transporters in skeletal muscle from type 2 (non-insulin-dependent) diabetic patients. Diabetologia (1990) 1.30

Abnormal regulation of protein tyrosine phosphatase activities in skeletal muscle of insulin-resistant humans. Diabetes (1991) 1.27

Phosphatidylinositol 3-kinase: a novel effector. Cell Growth Differ (1992) 1.22

The dynamics of the glucose transporter. Trends Biochem Sci (1988) 1.22

Gene expression of GLUT4 in skeletal muscle from insulin-resistant patients with obesity, IGT, GDM, and NIDDM. Diabetes (1992) 1.20

Insulin-receptor kinase activity of adipose tissue from morbidly obese humans with and without NIDDM. Diabetes (1987) 1.20

Glucocorticoid regulation of insulin receptor and substrate IRS-1 tyrosine phosphorylation in rat skeletal muscle in vivo. J Clin Invest (1993) 1.15

Skeletal muscle protein tyrosine phosphatase activity and tyrosine phosphatase 1B protein content are associated with insulin action and resistance. J Clin Invest (1994) 1.15

Insulin resistance in obese Zucker rat (fa/fa) skeletal muscle is associated with a failure of glucose transporter translocation. J Clin Invest (1992) 1.09

Diabetes-induced functional and structural changes in insulin receptors from rat skeletal muscle. J Clin Invest (1986) 1.09

Exercise training increases glucose transporter protein GLUT-4 in skeletal muscle of obese Zucker (fa/fa) rats. FEBS Lett (1990) 1.07

Insulin secretion, insulin resistance, and obesity. Int J Obes (1982) 1.06

A defective intramolecular autoactivation cascade may cause the reduced kinase activity of the skeletal muscle insulin receptor from patients with non-insulin-dependent diabetes mellitus. J Biol Chem (1989) 1.04

Insulin binding and glucose uptake differences in rodent skeletal muscles. Diabetes (1981) 1.01

Changes in tyrosine phosphorylation of insulin receptors and a 170,000 molecular weight nonreceptor protein in vivo in skeletal muscle of streptozotocin-induced diabetic rats: effects of insulin and glucose. Endocrinology (1992) 0.99

Components of signaling pathways for insulin and insulin-like growth factor-I in muscle myoblasts and myotubes. Endocrinology (1992) 0.99

Effects of hypercortisolemia and diabetes on skeletal muscle insulin receptor function in vitro and in vivo. Am J Physiol (1989) 0.93

Intrinsic differences of insulin receptor kinase activity in red and white muscle. J Biol Chem (1986) 0.90

Regulation of phosphatidylinositol 3-kinase by insulin in rat skeletal muscle. Am J Physiol (1993) 0.86

Articles by these authors

(truncated to the top 100)

Monoclonal dinitrophenyl-specific murine IgE antibody: preparation, isolation, and characterization. J Immunol (1980) 6.69

Perspectives on the basic reproductive ratio. J R Soc Interface (2005) 5.34

Gene for von Recklinghausen neurofibromatosis is in the pericentromeric region of chromosome 17. Science (1987) 5.11

Value-based pathology: a cost-benefit analysis of the examination of routine and nonroutine tonsil and adenoid specimens. Am J Clin Pathol (1997) 4.51

Sequence-specific interaction of R17 coat protein with its ribonucleic acid binding site. Biochemistry (1983) 4.09

Selective inhibition of receptor-coupled phospholipase C-dependent processes in human platelets and polymorphonuclear neutrophils. J Pharmacol Exp Ther (1990) 3.55

Usher syndrome 1D and nonsyndromic autosomal recessive deafness DFNB12 are caused by allelic mutations of the novel cadherin-like gene CDH23. Am J Hum Genet (2000) 3.48

Interaction of R17 coat protein with its RNA binding site for translational repression. J Biomol Struct Dyn (1983) 3.20

Gel retardation. Methods Enzymol (1991) 3.11

CD8(+) T cell-mediated spontaneous diabetes in neonatal mice. J Immunol (1996) 3.02

The gastric bypass operation reduces the progression and mortality of non-insulin-dependent diabetes mellitus. J Gastrointest Surg (2006) 2.93

Lipid oxidation is reduced in obese human skeletal muscle. Am J Physiol Endocrinol Metab (2000) 2.89

Nonsyndromic hearing impairment: unparalleled heterogeneity. Am J Hum Genet (1997) 2.82

The gut: a central organ after surgical stress. Surgery (1988) 2.76

Tandem binding in crystals of a trp repressor/operator half-site complex. Nature (1993) 2.65

Surgical treatment of obesity and its effect on diabetes: 10-y follow-up. Am J Clin Nutr (1992) 2.62

Carrier rates in the midwestern United States for GJB2 mutations causing inherited deafness. JAMA (1999) 2.56

Mutations in the human alpha-tectorin gene cause autosomal dominant non-syndromic hearing impairment. Nat Genet (1998) 2.52

Phenotypic and functional analysis of CD8(+) T cells undergoing peripheral deletion in response to cross-presentation of self-antigen. J Exp Med (2001) 2.49

Mutations in the novel protocadherin PCDH15 cause Usher syndrome type 1F. Hum Mol Genet (2001) 2.48

Oscillating behavior of carbohydrate granule formation and dinitrogen fixation in the cyanobacterium Cyanothece sp. strain ATCC 51142. J Bacteriol (1994) 2.48

Insulin receptor kinase in human skeletal muscle from obese subjects with and without noninsulin dependent diabetes. J Clin Invest (1987) 2.36

Congenital cytomegalovirus infection. N Engl J Med (1977) 2.35

Analysis of the HLA-restricted influenza-specific cytotoxic T lymphocyte response in transgenic mice carrying a chimeric human-mouse class I major histocompatibility complex. J Exp Med (1991) 2.33

Interaction of R17 coat protein with synthetic variants of its ribonucleic acid binding site. Biochemistry (1983) 2.30

A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group. N Engl J Med (1995) 2.29

Unicellular, aerobic nitrogen-fixing cyanobacteria of the genus Cyanothece. J Bacteriol (1993) 2.22

Maspin acts at the cell membrane to inhibit invasion and motility of mammary and prostatic cancer cells. Proc Natl Acad Sci U S A (1996) 2.20

Sequence of an HLA-DR alpha-chain cDNA clone and intron-exon organization of the corresponding gene. Nature (1982) 2.18

Optimal conditions for genetic transformation of the cyanobacterium Anacystis nidulans R2. J Bacteriol (1984) 2.17

Broadband observations of the naked-eye gamma-ray burst GRB 080319B. Nature (2008) 2.16

Organization and Function of Chlorophyll in Membranes of Cyanobacteria during Iron Starvation. Plant Physiol (1983) 2.13

Activation of low avidity CTL specific for a self epitope results in tumor rejection but not autoimmunity. J Immunol (1998) 2.10

A re-examination of risk estimates from the NIOSH Occupational Noise and Hearing Survey (ONHS) J Acoust Soc Am (1997) 2.09

Targeting p53 as a general tumor antigen. Proc Natl Acad Sci U S A (1995) 2.09

Congenital cytomegalovirus infection: diagnostic and prognostic significance of the detection of specific immunoglobulin M antibodies in cord serum. Pediatrics (1982) 2.07

Kinetic and thermodynamic characterization of the R17 coat protein-ribonucleic acid interaction. Biochemistry (1983) 2.07

Effect of iron deficiency and iron restoration on ultrastructure of Anacystis nidulans. J Bacteriol (1983) 2.03

Oral challenge tests for urticaria--an ethical dilemma. Br J Dermatol (1994) 1.98

Photosynthetic and phylogenetic primers for detection of anoxygenic phototrophs in natural environments. Appl Environ Microbiol (2001) 1.93

A comparison of whole-body turboSTIR MR imaging and planar 99mTc-methylene diphosphonate scintigraphy in the examination of patients with suspected skeletal metastases. AJR Am J Roentgenol (1997) 1.92

Pattern formation in the blue-green alga, Anabaena. I. Basic mechanisms. J Cell Sci (1973) 1.92

Metabolic imaging of malignant pleural mesothelioma with fluorodeoxyglucose positron emission tomography. Chest (1998) 1.91

Camptodactyly and simialr atraumatic flexion deformities of the proximal interphalangeal joints of the fingers. A study of thirty-one cases. J Bone Joint Surg Am (1968) 1.89

Bacterial RNA isolation with one hour centrifugation in a table-top ultracentrifuge. Biotechniques (1990) 1.87

Antigen concentration and precursor frequency determine the rate of CD8+ T cell tolerance to peripherally expressed antigens. J Immunol (1999) 1.86

Sequences related to HLA-DR alpha chain on human chromosome 6: restriction enzyme polymorphism detected with DC alpha chain probes. Proc Natl Acad Sci U S A (1983) 1.85

CD5-mediated negative regulation of antigen receptor-induced growth signals in B-1 B cells. Science (1996) 1.84

Peripheral tolerance to an islet cell-specific hemagglutinin transgene affects both CD4+ and CD8+ T cells. Eur J Immunol (1992) 1.83

Classification and nomenclature of viruses of cyanobacteria. Intervirology (1983) 1.83

Contribution of meniscal extrusion and cartilage loss to joint space narrowing in osteoarthritis. Clin Radiol (1999) 1.82

Transcriptional and translational regulation of nitrogenase in light-dark- and continuous-light-grown cultures of the unicellular cyanobacterium Cyanothece sp. strain ATCC 51142. J Bacteriol (1997) 1.82

Mutations in COL11A2 cause non-syndromic hearing loss (DFNA13). Nat Genet (1999) 1.82

The role of beta 2-microglobulin in peptide binding by class I molecules. Science (1990) 1.80

Isolation and characterization of photosystem I and II membrane particles from the blue-green alga, Synechococcus cedrorum. Biochim Biophys Acta (1978) 1.80

Eye signs in craniopharyngioma. Br J Ophthalmol (1975) 1.80

Sustained endotoxemia leads to marked down-regulation of early steps in the insulin-signaling cascade. Crit Care Med (2001) 1.78

Pattern formation in the blue-green alga Anabaena. II. Controlled proheterocyst regression. J Cell Sci (1973) 1.78

Recurrent meningitis and Mondini dysplasia. Arch Otolaryngol Head Neck Surg (1990) 1.77

Pendred syndrome, DFNB4, and PDS/SLC26A4 identification of eight novel mutations and possible genotype-phenotype correlations. Hum Mutat (2001) 1.77

Genomic structure and identification of novel mutations in usherin, the gene responsible for Usher syndrome type IIa. Am J Hum Genet (2000) 1.76

Hypoxia stimulates glucose transport in insulin-resistant human skeletal muscle. Diabetes (1995) 1.75

Blood component recalls in the United States. Transfusion (1999) 1.73

Tolerance to p53 by A2.1-restricted cytotoxic T lymphocytes. J Exp Med (1997) 1.73

Genetic analysis of NF1: identification of close flanking markers on chromosome 17. Genomics (1987) 1.73

Glutamine metabolism by the intestinal tract. JPEN J Parenter Enteral Nutr (1985) 1.71

Teratogenicity of 2-ethoxyethanol by dermal application. Drug Chem Toxicol (1982) 1.70

Chlorophyll-protein organization of membranes from the cyanobacterium Anacystis nidulans. Arch Biochem Biophys (1983) 1.69

Localization of the Usher syndrome type ID gene (Ush1D) to chromosome 10. Hum Mol Genet (1996) 1.69

Restoration of insulin responsiveness in skeletal muscle of morbidly obese patients after weight loss. Effect on muscle glucose transport and glucose transporter GLUT4. J Clin Invest (1992) 1.69

Biochemical changes in the collagen of the palmar fascia in patients with Dupuytren's disease. J Bone Joint Surg Am (1981) 1.69

Metronidazole and the isolation of temperature-sensitive photosynthetic mutants in cyanobacteria. J Bioenerg Biomembr (1980) 1.69

Clinical and metabolic efficacy of glutamine-supplemented parenteral nutrition after bone marrow transplantation. A randomized, double-blind, controlled study. Ann Intern Med (1992) 1.68

Tightly linked markers for the neurofibromatosis type 1 gene. Genomics (1987) 1.68

Mutations in the transcriptional activator EYA4 cause late-onset deafness at the DFNA10 locus. Hum Mol Genet (2001) 1.68

Challenge test battery in chronic urticaria. Br J Dermatol (1976) 1.67

Localization of Usher syndrome type II to chromosome 1q. Genomics (1990) 1.67

Prognostic value of FDG PET imaging in malignant pleural mesothelioma. J Nucl Med (1999) 1.67

A single dose of endotoxin increases intestinal permeability in healthy humans. Arch Surg (1988) 1.66

Bioregulation of lysosomal enzyme secretion from human neutrophils: roles of guanosine 3':5'-monophosphate and calcium in stimulus-secretion coupling. Proc Natl Acad Sci U S A (1975) 1.65

Regulation and sequence of the Synechococcus sp. strain PCC 7942 groESL operon, encoding a cyanobacterial chaperonin. J Bacteriol (1990) 1.64

Paternal origin of new mutations in von Recklinghausen neurofibromatosis. Nature (1990) 1.64

Nonsyndromic hearing impairment is associated with a mutation in DFNA5. Nat Genet (1998) 1.63

Why retrobulbar anaesthesia? Br J Ophthalmol (1988) 1.63

Skeletal muscle fiber composition is related to adiposity and in vitro glucose transport rate in humans. Am J Physiol (1995) 1.62

Mutants of Anabaena cylindrica altered in heterocyst spacing. Arch Microbiol (1975) 1.62

A common founder for the 35delG GJB2 gene mutation in connexin 26 hearing impairment. J Med Genet (2001) 1.61

A new paradigm for type 2 diabetes mellitus: could it be a disease of the foregut? Ann Surg (1998) 1.61

Related cell-surface antigens expressed with positional specificity in Drosophila imaginal discs. Proc Natl Acad Sci U S A (1984) 1.60

Translation activates the paused transcription complex and restores transcription of the trp operon leader region. Proc Natl Acad Sci U S A (1985) 1.59

Ten per cent polarized optical emission from GRB 090102. Nature (2009) 1.58

Alterations in skeletal muscle protein-tyrosine phosphatase activity and expression in insulin-resistant human obesity and diabetes. J Clin Invest (1997) 1.58

Leptin directly alters lipid partitioning in skeletal muscle. Diabetes (1997) 1.57

Highly polarized light from stable ordered magnetic fields in GRB 120308A. Nature (2013) 1.57

Recognition of conformational determinants on H-2 by cytolytic T lymphocytes. Nature (1982) 1.56

Construction of a hybrid plasmid capable of replication in the bacterium Escherichia coli and the cyanobacterium Anacystis nidulans. J Bacteriol (1982) 1.56

Performance of a whole-body PET scanner using curve-plate NaI(Tl) detectors. J Nucl Med (2001) 1.56

Giant-cell tumors of the bones of the hand. J Hand Surg Am (1980) 1.55

Mutations in the KCNQ4 gene are responsible for autosomal dominant deafness in four DFNA2 families. Hum Mol Genet (1999) 1.54

Recombinant human erythropoietin in the treatment of anemia associated with human immunodeficiency virus (HIV) infection and zidovudine therapy. Overview of four clinical trials. Ann Intern Med (1992) 1.53